Luc D.
- Country
- France
- Department
- Réanimation néonatale
Research Overview
- Safety Assessment of ELGN-2112 (Insulin Human) in Preterm Infants with Intestinal Malabsorption: A Double-Blind, Randomized, Placebo-Controlled Study
- Evaluation of Intravenous Sildenafil Combined with Therapeutic Hypothermia on Neuroprotection in Term Neonates with Hypoxic-Ischemic Encephalopathy
- Evaluation of Epinephrine Efficacy in Cardiopulmonary Resuscitation for Term Neonates with Cardiorespiratory Arrest in the Delivery Room
Data & Insights
Has run more than one trial at 2 of 22 partner sites.
Specializations
Neonatal Critical Care
This investigator specializes in treating hypoxic-ischemic encephalopathy in newborns, with particular focus on therapeutic interventions combining controlled hypothermia treatments. The research extends to investigating neuroprotective strategies for improving survival outcomes without brain lesions in term neonates.
- Brain Protection Strategies
- Therapeutic Hypothermia
- Neonatal Neurological Care
Preterm Infant Care
The investigator focuses on addressing intestinal malabsorption in extremely preterm infants and those with intrauterine growth restriction. Their work encompasses specialized care for infants born before 26 weeks gestational age and growth-restricted infants born between 26-32 weeks.
- Extremely Preterm Care
- Growth Restriction Management
- Gastrointestinal Development
Emergency Neonatal Resuscitation
The investigator develops advanced techniques for cardiopulmonary resuscitation in newborns, specifically focusing on umbilical vein catheterization procedures. Their work aims to improve emergency response times and outcomes in full-term newborns experiencing circulatory arrest at birth.
- Delivery Room Resuscitation
- Vascular Access Techniques
- Emergency Response Protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.